Heparin Infusion After PCI
Evidence-Based Recommendations for Anticoagulation Management After PCI
- The American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend discontinuing anticoagulant therapy after PCI for uncomplicated cases, with a Level of Evidence: B 1, 2
- After successful PCI, the focus should shift to monitoring for recurrent ischemia, achieving hemostasis at the catheter insertion site, and preventing contrast-induced renal failure 3
- For patients undergoing PCI without complications, heparin infusion should be discontinued after the procedure, as recommended by the ACC 1
- For patients with specific clinical indications for continued anticoagulation, subcutaneous administration of unfractionated heparin may provide a safer and less costly means of extending antithrombin therapy than intravenous unfractionated heparin 4
- In patients requiring long-term anticoagulation, oral anticoagulant therapy can be resumed within 24 hours after PCI, based on assessment of bleeding risk and post-procedure complications, according to the ACC 5, 6
Post-PCI Antithrombotic Management
- The ACC recommends continuing aspirin, with a Level of Evidence: A 1, 2
- A loading dose of clopidogrel should be administered if not started before diagnostic angiography, with a Level of Evidence: A 1
- For high-risk patients, particularly those who are troponin-positive, consider glycoprotein IIb/IIIa inhibitors if not started before diagnostic angiography, as recommended by the ACC 1
Considerations for Special Populations
- For patients on chronic oral anticoagulation who undergo PCI, assess access site for adequacy of hemostasis before restarting anticoagulation, and consider patient factors including history of recent bleeding, body habitus, and platelet abnormalities, according to the ACC 7
- In most patients, oral anticoagulant therapy can be resumed within 24 hours after PCI, as recommended by the ACC 7, 8